Allegra Medical Technologies (ASX:AMT) 3-Year Revenue Growth Rate : 0.00% (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Allegra Medical Technologies 3-Year Revenue Growth Rate?

Allegra Medical Technologies's Revenue per Share for the six months ended in Dec. 2023 was A$0.00.

During the past 12 months, Allegra Medical Technologies's average Revenue per Share Growth Rate was -85.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Allegra Medical Technologies was 11.20% per year. The lowest was -28.50% per year. And the median was -8.35% per year.

Competitive Comparison of Allegra Medical Technologies's 3-Year Revenue Growth Rate

For the Medical Devices subindustry, Allegra Medical Technologies's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Allegra Medical Technologies's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Allegra Medical Technologies's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Allegra Medical Technologies's 3-Year Revenue Growth Rate falls into.

Allegra Medical Technologies 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Allegra Medical Technologies (ASX:AMT) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Allegra Medical Technologies 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Allegra Medical Technologies's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Allegra Medical Technologies (ASX:AMT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Allegra Medical Technologies Ltd (ASX:AMT) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

18-20 Orion Road, Level 8, Lane Cove West, Sydney, NSW, AUS, 2066

Website

https://www.allegraorthopaedics.com

Allegra Medical Technologies Ltd is engaged in the research, product development, and manufacturing of medical devices including prosthetic implant tools. It offers adult and adolescent clavicle fixation systems and pins; shoulder implants; hand fracture plates and ulna heads, compression screws, distal radius systems, and hand fracture systems; hip stems and heads, CSF cups, and evolution and resurfacing hip products; and knee replacement systems among others. It operates in two segments Orthopaedics Division, which derives the majority of its revenue sells and distributes its portfolio of medical device products. Innovation Division which invests resources into the development and commercialization of new products to take to market.